Company profile for Edgewise Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Edgewise Therapeutics is a new company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise builds on our extensive experience in ...
Edgewise Therapeutics is a new company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise builds on our extensive experience in drug development and skeletal muscle research. We have built a custom discovery workshop for the discovery and optimization of novel therapeutics for a broad set of indications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3415 Colorado Ave Boulder, CO 80303
Telephone
Telephone
303.735.8373
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/edgewise-therapeutics-appoints-commercial-biotech-executive-christopher-martin-to-its-board-of-directors-302620999.html

PR NEWSWIRE
20 Nov 2025

https://www.prnewswire.com/news-releases/edgewise-therapeutics-announces-appointment-of-michael-nofi-as-chief-financial-officer-and-the-retirement-of-current-cfo-r-michael-carruthers-302609547.html

PR NEWSWIRE
10 Nov 2025

https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-third-quarter-2025-financial-results-and-recent-business-highlights-302606313.html

PR NEWSWIRE
06 Nov 2025

https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-302601499.html

PR NEWSWIRE
03 Nov 2025

https://www.prnewswire.com/news-releases/edgewise-therapeutics-to-present-on-sevasemten-for-becker-and-duchenne-muscular-dystrophies-at-the-30th-international-annual-congress-of-the-world-muscle-society-302573117.html

PR NEWSWIRE
02 Oct 2025

https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-302545849.html

PR NEWSWIRE
03 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty